Autifony Therapeutics
Gabriele Dimitri is a medicinal chemist currently working at Autifony Therapeutics since September 2023. Prior to this role, Gabriele served as a research scientist at Evotec from April 2021 to September 2023 and gained experience as an intern pharmacist at Farmacia Aurelio Sammaruga from August 2019 to November 2020, focusing on drug prescription processing and counseling on cosmetics, nutraceuticals, and medical devices. Additionally, Gabriele held the position of visiting research student at the University of Helsinki from February 2020 to October 2020, where the research involved the synthesis of flavonols and flavonol derivatives as potential selective quorum sensing inhibitors of Pseudomonas aeruginosa, contributing to a Master Thesis in medicinal chemistry under the supervision of Jayendra Patel.
This person is not in any teams
This person is not in any offices
Autifony Therapeutics
Autifony Therapeutics Limited is a UK-based company that specializes in researching treatments for hearing disorders, tinnitus, age-related hearing loss, and schizophrenia.